| MolName | 2-[(5E)-5-[[2-(4-carbamoylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid |
| MolecularFormula | C20H19N5O5S2 |
| Smiles | NC(C(CC1)CCN1C(N=C1N2C=CC=C1)=C(/C=C(\C(N1CC(O)=O)=O)/SC1=S)C2=O)=O |
| InChI | InChI=1S/C20H19N5O5S2/c21-16(28)11-4-7-23(8-5-11)17-12(18(29)24-6-2-1-3-14(24)22-17)9-13-19(30)25(10-15(26)27)20(31)32-13/h1-3,6,9,11H,4-5,7-8,10H2,(H2,21,28)(H,26,27) |
| InChIK | XOSVUNNASKSYSR-UHFFFAOYSA-N |
| TotalMolweight | 473.533 |
| Molweight | 473.533 |
| MonoisotopicMass | 473.08276 |
| CLogP | -1.6695 |
| CLogS | -3.532 |
| H Acceptors | 10 |
| H Donors | 2 |
| TotalSurfaceArea | 331.37 |
| Relative PSA | 0.44717 |
| PolarSurfaceArea | 194 |
| Druglikeness | 2.6705 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.46875 |
| Fragments | 1 |
| Non HAtoms | 32 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| Rotatable Bond | 5 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Sp3Atoms | 9 |
| Symmetricatoms | 2 |
| Amides | 3 |
| BasicNitrogens | 1 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 2-[(5E)-5-[[2-(4-carbamoylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid | 2 - 2-[(5E)-5-[[2-(4-carbamoylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid